Article
Novel Mutations L228I and Y232H Cause Nonnucleoside Reverse Transcriptase Inhibitor Resistance in Combinational Pattern.
AIDS research and human retroviruses - 1 Sept 2016
Zhang Xiao-Min, Zhang Qiwei, Wu Hao, Lau Terrence Chi-Kong, Liu Xuan, Chu Hin, Zhang Ke, Zhou Jie, Chen Zhi-Wei, Jin Dong-Yan, Zheng Bo-Jian
Abstract excerpt
The emergence of drug resistance mutations is increasing after the implementation of highly active antiretroviral therapy. To characterize two novel mutations L228I and Y232H in the primer grip of reverse transcriptase (RT) of HIV-1 circulating recombination form 08_BC (CRF08_BC) subtype, both mutant clones were constructed to determine their impacts on viral phenotypic susceptibility and replication capacity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
